Nasdaq's $1 Warning: Most Companies Stay Listed, Most Shares Fall
We followed 145 Nasdaq companies that disclosed their first minimum bid price notice in the first half of 2025. By October 2026, three in four were still…
We followed 145 Nasdaq companies that disclosed their first minimum bid price notice in the first half of 2025. By October 2026, three in four were still…
On May 28, 2025, Nasdaq told Opendoor (OPEN $1.13 -5.04%) that its shares had closed below $1.00 for 30 business days in a row. The company did what most companies in that position do: it called a special meeting to ask shareholders for permission to do a reverse split. Then the stock ran. Opendoor closed at $1.00 or more on 12 straight trading days from July 15 to July 30, Nasdaq closed the matter, and the board cancelled the meeting.
Opendoor is the story everyone remembers, but it isn't the typical one. We followed every Nasdaq company that disclosed its first minimum bid price notice in the first half of 2025, 145 of them, to October 26, 2026. Most are still listed. Most did a reverse split to get there. And for most of the people who held the stock on the day the letter was disclosed, the shares are worth less now.
Nasdaq requires a listed stock to close with a bid of at least $1.00. When the closing bid has been below that for 30 consecutive business days, Nasdaq sends a deficiency letter, and the company has four business days to disclose it, usually in an 8-K under Item 3.01. The letter starts a compliance period of 180 calendar days. To regain compliance, the stock must close at $1.00 or more for at least 10 consecutive business days, and Nasdaq's staff can ask for up to 20.
A company that hasn't recovered after 180 days can get a second 180 days if it meets the other initial listing standards for the Nasdaq Capital Market, moving there if necessary, and tells Nasdaq it will cure the deficiency with a reverse split if needed. After that comes a delisting determination, which the company can appeal to a Hearings Panel.
Two changes approved by the SEC on January 17, 2025, made the end of that road shorter, and the companies in this study went through the process under them:
A separate rule applies at the bottom: a stock that closes at $0.10 or less for ten consecutive trading days during a compliance period gets a delisting determination immediately.
Three in four companies are still listed, which sounds better than it is. Of the 30 still listed but trading under $1, 20 are on their second trip through the process: since the first letter they have received a new one, or an extension or delisting decision that could only follow a new one. Blink Charging (BLNK $0.39 -7.16%) is one: it got its first letter in May 2025, was back above $1 by September, received a new letter in January 2026, and in July was granted a second 180 days, until January 25, 2027, after telling Nasdaq it would do a reverse split if necessary. It closed at $0.38 on October 26.
The 19 delisted companies include Stardust Power, which did a 1-for-10 reverse split in September 2025, fell below $1 again, and then closed at $0.10 or less for ten trading days in October 2026. Nasdaq said it would suspend its shares on October 23, and under the January 2025 rule a hearing request doesn't stop a suspension.
Some companies don't need to do anything. Of the 126 companies with price history in our data, 59 (46.8%) closed at $1.00 or more on ten straight trading days before doing any reverse split. The median company got there 102 days after the letter, and 46 of the 59 did it inside the first 180 days. 44 of them never split at all.
Recovering didn't always last. 24 of the 59 later started the process over with a new letter, and 22 are back under $1 today.
The best predictor of a recovery was the price when the letter arrived. A stock at $0.85 needs an 18% rise to clear $1; a stock at $0.30 needs to more than triple.
| Price when the letter was disclosed | Companies | Back above $1 before any split | Did a reverse split | Delisted or bankrupt |
|---|---|---|---|---|
| Under $0.50 | 23 | 4 | 17 | 8 |
| $0.50 to $0.79 | 73 | 37 | 43 | 8 |
| $0.80 or more | 30 | 18 | 18 | 2 |
The median stock closed at $0.68 on the day its letter was disclosed.
85 of the 145 companies (58.6%) did at least one reverse split after the letter. Most waited. Only 31 split within the first 180 days; 45 split between day 181 and day 360, which is when the second compliance period runs and when Nasdaq expects the split it was promised.
| Ratio of the first reverse split | Companies |
|---|---|
| Less than 1-for-10 | 11 |
| 1-for-10 to 1-for-19 | 27 |
| 1-for-20 to 1-for-49 | 37 |
| 1-for-50 or more | 10 |
The median first split was 1-for-20. The ratio is usually chosen with room to spare, because a split that lands the stock at $1.10 can be undone by a few bad weeks.
Some companies split again and again. 14 did more than one reverse split after the letter and 3 did at least three. Vivakor did a 1-for-200 split in March 2026, a 1-for-20 in July and a 1-for-15 in October, so 60,000 shares from before March are now one. Its stock closed at $1.32 on October 26, on a split-adjusted basis a tiny fraction of the $0.88 it traded at when its letter was disclosed in March 2025.
A split also doesn't fix whatever pushed the stock under $1. At least 13 of the 85 companies that split fell back below $1 long enough to start the process again. Under the January 2025 rule, a company that falls under $1 again within a year of its split gets no new compliance period, only a delisting determination.
The split worked best when something else changed too. Nektar Therapeutics (NKTR $36.44 -2.23%) got its letter in April 2025 at $0.55, did a 1-for-15 split in June, and closed at $37.45 on October 26, 2026, equivalent to about $2.50 per share from before the split.
For anyone who held the stock, the more useful question is what the shares did. We measured the change from the close on the day each company disclosed its letter to its latest close in October 2026, adjusted for splits, for the 107 still-listed companies with a price on both dates.
The gap between the last two isn't evidence that reverse splits destroy value. It's the other way around: the companies whose stock recovered on its own never needed a split, so the split marks the companies that didn't recover. What the numbers do show is that the typical stock kept falling after the letter. And these figures leave out the 37 companies no longer listed: the 18 delisted or bankrupt ones with prices in our data lost a median 97.7% by their last close.
A bid-price letter often comes with company. 58 of the 145 companies also received a notice for another listing rule at some point in 2025 or 2026, most often minimum stockholders' equity (22 companies) or a late filing (16). 16 of those 58 (27.6%) were delisted or went bankrupt, against 10 of the 87 (11.5%) that only had the price problem.
Drug developers were the largest group: 61 of the 145 companies (42.1%) are classified by the SEC as pharmaceutical preparations or biological products. They were also the largest group in our study of going-concern warnings. Small drug developers usually pay for their trials by selling new shares, which keeps adding to the share count while they wait for results.
The letters themselves tend to arrive quietly. In our study of 8-K timing, 38.6% of listing deficiency notices went public on a Friday after 4 p.m.
A Nasdaq bid-price letter is not a death sentence: three in four companies that got one in early 2025 were still listed in October 2026, and nearly half got back above $1 at least once without a reverse split. But the way most of them stayed listed was a reverse split, usually at the last moment, and for shareholders the letter was more often a warning than a bottom. The price on the day of the letter is the first number to look at. Under 50 cents, only 4 of 23 companies recovered on their own and a third were gone by October 2026.
This study describes public filings and market prices. It is not investment advice.
Texto de equibles.com tal como lo publicó, leído de su página y mostrado aquí con el formato de El Autómata. El original, en equibles.com · Volver a la noticia de El Autómata